What does FIGS do and what are its main business segments?

What were the key takeaways from FIGS’s earnings call?

What guidance did FIGS's management provide for the next earnings period?

What is FIGS's gross profit margin?

What were the key takeaways from FIGS's earnings call?

What is the revenue and EPS growth rate for FIGS year over year?

What is FIGS's latest dividend and current dividend yield?

What is the market's earnings forecast for FIGS next quarter?

- **Revenue Beat**: Q3 revenue up 8% YoY to $151.7M, with full-year 2025 guidance raised to ~7% growth.
- **Margin Expansion**: Adjusted EBITDA margin improved to 12.4%, with full-year 2025 guidance at ~10.3% (vs. prior 8.5-9%).
- **Tariff Mitigation**: 2026 tariff impact estimated at 440bps, partially offset by cost optimizations and supplier savings.
- **Strategic Growth**: 3 new community hubs opening in NYC, Houston, and Chicago; China expansion via Tmall.
- **Customer Engagement**: Active customers hit 2.8M, with 40% of store visitors new to the brand.

**【CEO Summary Section】**
- **Revenue Growth**: Q3 net revenues increased 8% YoY to $151.7 million, driven by 8% growth in scrubwear and 7% in non-scrubwear. Full-year 2025 revenue guidance raised to ~7% growth, up from low single digits.
- **Product Strategy Success**: Improved function and fit, expanded head-to-toe solutions (e.g., ArchTek compression socks), and strategic inventory investments. Gross margin expanded 280bps to 69.9% due to lower discounts, better returns processing, and tariff mitigation efforts.
- **International Expansion**: Expanded to nearly 60 markets by end of Q3, including China via Tmall. Canada, UK, and Mexico saw deep investments in brand marketing and logistics.
- **Community Hubs**: Opened 3 new stores (NYC, Houston, Chicago) with updated designs and merchandising. 40% of store customers are new to the brand, and 30% become omnichannel shoppers.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA margin improved to 12.4% (vs. 3.4% YoY), with full-year 2025 margin guidance raised to ~10.3% (vs. prior 8.5-9%).
- **Tariff Mitigation**: 2026 tariff impact estimated at 440bps, partially offset by lower discounts, freight optimizations, and supplier negotiations.
- **Balance Sheet**: $241.5M net cash, with $52M remaining under share repurchase program.
- **Q4 Outlook**: Strongest quarterly revenue growth of the year, driven by business-as-usual selling days and reduced promotions. Gross margin expected to decline modestly due to tariffs but better than prior guidance.

**【Q&A Highlights】**
- **Gross Margin Sustainability**: CEO emphasized long-term focus on offsetting tariffs through efficiency gains, while CFO noted 2026 margin guidance assumes ~440bps tariff drag.
- **Customer Trends**: Active customers reached 2.8M (4% YoY growth), with AOV up 6% to $114. Reactivation rates improved, and 40% of community hub customers are new.
- **Community Hubs**: NYC store opening in Upper East Side near major hospitals; 3 new stores expected to drive incremental sales and brand engagement.
- **Teams Strategy**: Upgraded technology platform for institutional sales, supporting customizable solutions and gifting capabilities. Teams business is accretive to margins despite lower gross margin due to discounts.

FIGS, Inc. (FIGS) Q3 2025 Earnings Call Transcript

- **Revenue Beat Expectations**: 6% YoY growth driven by 8% scrubwear expansion and U.S. market recovery.
- **Profitability Boost**: EBITDA margin jumps to 12.9% due to cost savings and efficient expense management.
- **Tariff Mitigation Plan**: 150 basis points impact offset by supplier diversification, pricing actions, and cost controls.
- **Customer Engagement**: AOV +4%, active customers +4%, with hubs capturing 40% new users.
- **International Growth**: 20% YoY expansion with Japan and South Korea launches, targeting 8.5-9% EBITDA margin for 2025.

**【CEO Summary Section】**
- **Revenue Growth**: Q2 net revenues increased 6% YoY to $152.6 million, driven by 8% growth in scrubwear (83% of total revenue) and strong performance in the U.S. market (+4%).
- **Product & Marketing Success**: Enhanced product assortment, fit improvements, and Nurses Week campaign (900M impressions) contributed to AOV growth of 4% to $117 and 4% increase in active customers to 2.7 million.
- **International Expansion**: 20% YoY growth in international markets, with launches in Japan and planned South Korea entry. Community hubs in Houston, NYC, and Chicago aim to capture new customers (40% of hub traffic is first-time buyers).
- **Tariff Mitigation**: 150 basis points of expected tariff impact for 2025, with strategies including supplier diversification (Vietnam, Jordan), cost savings, and targeted pricing.

**【CFO Financial Commentary】**
- **Profitability**: Adjusted EBITDA margin improved 390 basis points YoY to 12.9%, driven by 22.6% selling expense rate (down from 25.6%) and disciplined cost management.
- **Gross Margin**: 67% gross margin, contracting 40 basis points due to tariffs and inventory reserves, but offset by lower return rates.
- **Balance Sheet**: $238.8 million in net cash, with inventory up 14% YoY (8% unit growth) due to higher-cost goods and pre-positioning for tariffs.
- **Outlook**: Full-year 2025 revenue expected to grow low single digits, with Q3 guidance of 0-2% growth. Adjusted EBITDA margin range updated to 8.5-9% (vs. prior 7.5-8.5%).

**【Q&A Key Highlights】**
- **AOV Drivers**: Product mix (40%), returns (20%), and pricing (40%). AOV growth expected to continue but moderate due to reduced promotions.
- **Tariff Strategy**: Pricing will be last resort, with focus on supplier negotiations, freight optimization, and G&A savings. 2026 tariff impact to be addressed through same levers.
- **Promotional Pullback**: Q3/Q4 promo days reduced by 50%, with baseline days productivity up 10-20%. This creates headwinds but supports long-term brand health.
- **Community Hubs**: NYC and Chicago locations to open in Q4, with design updates and focus on proximity to major health care institutions.


FIGS (FIGS)-7 Aug 25-2025 Q2 Earnings call transcript

- **Revenue Beat & Margin Strength**: Q1 revenue up 5% YoY to $124.9M, AOV hits record $119, EBITDA margin 7.2% vs. 5.5-6% target.
- **Tariff Mitigation Progress**: 10% tariffs expected to impact 2025 margins by 100-150bps, with cost savings initiatives offsetting 60-70%.
- **International Expansion Momentum**: Japan launch Q2, South Korea H2, international sales +16% YoY driven by Mexico, Europe.
- **Community Hub Success**: Houston store near Texas Medical Center to open Q2, 40% of store customers new to FIGS.
- **Nurses Week Viral Campaign**: 10M+ impressions, reinforcing brand connection with healthcare professionals.

**【CEO Opening Remarks】**
- Q1 2025 revenue grew 5% YoY to $124.9M, exceeding expectations, driven by U.S. market recovery and normalization of scrubwear demand post-COVID.
- AOV reached a record $119, up 3% YoY, reflecting higher full-price sales and product mix.
- Adjusted EBITDA margin of 7.2% exceeded the 5.5-6% target, despite tariff challenges.
- Key initiatives: Japan and South Korea market entries, TEAMS business expansion, and Community Hub openings in Houston and beyond.

**【CFO Financial Highlights】**
- Gross margin contracted 130bps to 67.6%, due to promotional activity and mix shifts.
- Selling expenses rose to 26.2% of revenue, driven by fulfillment center costs and shipping investments.
- Marketing expense remained stable at 14.5%, supporting brand awareness and customer reactivation.
- Free cash flow of $7.9M, with net cash of $251.2M, enabling strategic investments.

**【Tariff Mitigation & Strategy】**
- Current 10% tariffs on Jordan and Vietnam production expected to increase costs by 100-150bps in 2025.
- Mitigation efforts: supply chain efficiency, renegotiated supplier terms, and delayed pricing decisions to preserve affordability for healthcare workers.
- Long-term focus on scaling fulfillment center and optimizing logistics for $1B+ revenue capacity.

**【International & TEAMS Growth】**
- International sales grew 16% YoY, led by Mexico, Europe, and Middle East, despite Canadian tariff-related softness.
- TEAMS business booked first outbound orders with a major healthcare provider, targeting 15% of scrubs market share.
- Japan launch planned for Q2, leveraging urban concentration and demand for fashion-functional products.

**【Community Engagement】**
- Nurses Week campaign achieved viral reach, with 10M+ impressions, reinforcing brand connection with healthcare professionals.
- Houston Community Hub near Texas Medical Center to open Q2, targeting 100K+ healthcare workers.
- 40% of store customers are new to FIGS, with 30% becoming omnichannel purchasers.

**【Risks & Outlook】**
- 2025 net revenue expected down low-single digits YoY, with Q2 flat growth and H2 headwinds from reduced promotions.
- Adjusted EBITDA margin guidance of 7.5-8.5%, reflecting tariff mitigation progress.
- Tariff impacts to flow through P&L in H2, with cost mitigation strategies to offset 100-150bps of margin pressure.

FIGS (FIGS)-8 May 25-2025 Q1 Earnings call transcript

- **Revenue resilience**: Q4 beat with 5% YoY growth despite promotional recalibration, driven by repeat customers and international expansion (45% growth). 
- **Margin management**: 2024 ended with $245M net cash, but 2025 EBITDA flat due to reduced promotions (-200bps top-line) and DC inefficiencies. 
- **Growth engines**: FORMx fabric innovation, B2B teams expansion (~15% of $1B+ global B2B opportunity), and Asian market launches (Japan/SKorea 2025). 
- **Risk mitigation**: $50M buyback program and 2025 capex reduction support financial flexibility amid near-term headwinds. 


**【CEO Summary Section】**
- Q4 revenue grew 5% YoY to $151.8M, driven by repeat customer traffic and positive scrubwear/non-scrubwear mix. International revenue surged 45% to 16% of total. 
- 2024 full year revenue reached $555.6M (+2% YoY), with record $81M operating cash flow and $245M net cash. 
- 2025 priorities: (1) Promotional recalibration (curtailing site-wide promos), (2) Fit standardization expansion, (3) Pause on Canadian DC to focus on US network efficiency. 
- New product launches include FORMx fabric line and footwear partnerships with New Balance. 
- Global expansion focus on Asia (Japan/SKorea launches in 2025) and B2B teams growth (~15% of industry opportunity). 

**【CFO Financial Commentary】**
- Q4 gross margin 67.3% (-20bps YoY) due to non-scrubwear mix and product transitions. 
- Selling expenses 25% of rev (vs 19.4% YoY) due to DC inefficiencies and international shipping. 
- 2025 guidance: Revenue down low single-digits YoY, flat gross margin, EBITDA 9-9.5%. 
- 2025 capex $5M (down from $17M) as DC build-out completes. 
- Share buyback program expanded by $50M, with $4.6M remaining under current plan. 

**【Q&A Highlights】**
- **Promotional Strategy**: 2025 will see ~200bps top-line headwind from reduced promotions, but expects reengaged lapsed customers to offset. 
- **Supply Chain**: Pausing Canadian DC to optimize US network; expects 2025 shipping costs to rise with international growth. 
- **Margins**: 2025 EBITDA margin flat YoY due to stock-based comp decline offsetting top-line pressure. 
- **New Product**: FORMx fabric line expected to differentiate brand; footwear sales up 13% in Q4 with 3447 New Balance style outperforming. 
- **Customer Metrics**: Active customers +3% YoY but AOV down 1%, with churn dynamics showing lapsed customer reengagement. 


FIGS

FIGS fundamentals

Earnings Call

You can ask Aime